Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,571.34
(
-0.15%
)
US TECH 100
23,456.40
(
-0.27%
)
Dow Jones
46,253.48
(
0.10%
)
Brent Oil
100.58
(
3.91%
)
Bitcoin
69,385.00
(
-2.14%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 187619

Tuesday, 04/07/2015 11:12:09 AM

Tuesday, April 07, 2015 11:12:09 AM

Post# of 257275
EGRX receives US patent on low-sodium formulation of generic Treanda:

http://finance.yahoo.com/news/eagle-pharmaceuticals-announces-patent-low-145100715.html

Eagle Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (“USPTO”) has granted Patent No. 9,000,021 for the use of bendamustine for treating patients requiring restricted fluid and/or sodium intake. The patent issued today expires in March 2033.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today